IFNG and neoplasm: Based on this, Lohmueller et al. designed an anti-biotin CAR-T and confirmed its activation induced by biotinylated bispecific antibody (anti-CD19 and CD20)-coated tumor cells, which further mediated tumor cell cleavage and interferon (IFN)-γ production in an antibody dose-dependent manner [51].